Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing the efficacy of different surfactant on critical neonatal respiratory distress syndrome
ChiCTR-OPN-17011344Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital, Huazhong University of Science and Technology
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of calfactant and Poractant alfa in respiratory distress syndrome (RDS) (2 arms), sponsored by Tongji Hospital, Huazhong University of Science and Technology. Primary endpoints: Blood gas analysis, Bronchopulmonary dysplasia (BPD) and 1 more. Planned start May 2017; status: not yet recruiting.
02
Drugs
calfactantPoractant alfa
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on ChiCTR-OPN-17011344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17011344.